Sign in or Register   Sign in or Register
  |  

Mouse Anti-NDP Recombinant Antibody (7H103) (CBMAB-N1565-WJ)

This product is a Mouse antibody that recognizes NDP. The antibody 7H103 can be used for immunoassay techniques such as: ELISA, WB.
See all NDP antibodies

Summary

Host Animal
Mouse
Specificity
Human, Mouse
Clone
7H103
Antibody Isotype
IgG1
Application
ELISA, WB

Basic Information

Specificity
Human, Mouse
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Lyophilized
Buffer
PBS, 5% Trehalose
Concentration
0.5 mg/mL
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
NDP, Norrin Cystine Knot Growth Factor
Introduction
This gene encodes a secreted protein with a cystein-knot motif that activates the Wnt/beta-catenin pathway. The protein forms disulfide-linked oligomers in the extracellular matrix. Mutations in this gene result in Norrie disease and X-linked exudative vitreoretinopathy. [provided by RefSeq, Feb 2009]
Entrez Gene ID
Human4693
Mouse17986
UniProt ID
HumanQ00604
MouseP48744
Alternative Names
NDP, Norrin Cystine Knot Growth Factor; X-Linked Exudative Vitreoretinopathy 2 Protein; Norrie Disease (Pseudoglioma); Norrie Disease Protein; EVR2; Exudative Vitreoretinopathy 2 (X-Linked); Norrin; FEVR; ND;
Function
Activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. Plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. Acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1). May be involved in a pathway that regulates neural cell differentiation and proliferation. Possible role in neuroectodermal cell-cell interaction.
Biological Process
Decidualization Source: Ensembl
Extracellular matrix-cell signaling Source: Ensembl
Nervous system development Source: ProtInc
Norrin signaling pathway Source: BHF-UCL
Positive regulation of DNA-binding transcription factor activity Source: Ensembl
Positive regulation of transcription, DNA-templated Source: BHF-UCL
Retina vasculature morphogenesis in camera-type eye Source: Ensembl
Vacuole organization Source: ProtInc
Visual perception Source: ProtInc
Wnt signaling pathway Source: UniProtKB-KW
Cellular Location
Secreted
Involvement in disease
Norrie disease (ND):
Recessive disorder characterized by very early childhood blindness due to degenerative and proliferative changes of the neuroretina. Approximately 50% of patients show some form of progressive mental disorder, often with psychotic features, and about one-third of patients develop sensorineural deafness in the second decade. In addition, some patients have more complex phenotypes, including growth failure and seizure.
Vitreoretinopathy, exudative 2 (EVR2):
A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery.

Huang, L., Sun, L., Li, X., Li, S., Zhang, T., Zhang, Z., & Ding, X. (2023). NDP-related retinopathies: clinical phenotype of female carriers. British Journal of Ophthalmology, 107(8), 1151-1155.

Scruggs, B. A., Reding, M. Q., & Schimmenti, L. A. (2022). NDP-related retinopathies.

Wang, H., Liu, Z., Zhou, Y., Ma, Y., & Tao, D. (2022). A novel frameshift c. 22_25dupGCAT mutation of the NDP gene in a Chinese infant with Norrie disease: A case report. Medicine, 101(1).

Gong, Y., Liu, Z., Zhang, X., Shen, S., Xu, Q., Zhao, H., ... & Zheng, Q. Y. (2022). Endolymphatic Hydrop Phenotype in Familial Norrie Disease Caused by Large Fragment Deletion of NDP. Frontiers in Aging Neuroscience, 14, 771328.

Peng, Y., Zhao, R., Dai, E., Peng, L., He, Y., Li, S., & Yang, M. (2022). Whole-exome sequencing reveals novel NDP variants in X-linked familial exudative vitreoretinopathy. European Journal of Ophthalmology, 32(6), 3220-3226.

Zhou, Y., Shapiro, M. J., Burton, B. K., Mets, M. B., & Kurup, S. P. (2021). Case report: A case of Norrie disease due to deletion of the entire coding region of NDP gene. American Journal of Ophthalmology Case Reports, 23, 101151.

Joyce, H., Burmeister, L. M., Wright, H., Fleming, L., Oliver, J. A., & Mellersh, C. (2021). Identification of a variant in NDP associated with X-linked retinal dysplasia in the English cocker spaniel dog. Plos one, 16(5), e0251071.

Zhu, X., Sun, K., Huang, L., Ma, S., Hao, F., Yang, Z., ... & Zhu, X. (2020). Identification of novel mutations in the FZD4 and NDP genes in patients with familial exudative vitreoretinopathy in South India. Genetic testing and molecular biomarkers, 24(2), 92-98.

Bao, Y., Yang, J., Chen, L., Chen, M., Zhao, P., Qiu, S., ... & Zhang, G. (2019). A novel mutation in the NDP gene is associated with familial exudative vitreoretinopathy in a southern Chinese family. Genetic Testing and Molecular Biomarkers, 23(12), 850-856.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-NDP Recombinant Antibody (7H103)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare